{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-000042","form_type":"8-K","ticker":"XTNT","cik":"0001453593","company_name":"Xtant Medical Holdings, Inc.","filed_at":"2022-01-03T23:59:59+00:00","discovered_at":"2026-05-14T18:04:06.535751+00:00","generated_at":"2026-06-27T21:20:12.004645+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Xtant Medical appoints Scott Neils as interim CFO; Greg Jensen departs effective Jan 3, 2022","bullets":["Greg Jensen, VP Finance and CFO, terminated effective January 3, 2022.","Scott Neils, previously Controller since August 2019, appointed Interim CFO.","Neils receives $300,000 base salary, 35% target bonus, 109,164 options and 88,983 RSUs.","Jensen expected to enter standard separation agreement with severance per employment contract."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-000042","json":"https://secwatch.observer/filing/0001493152-22-000042.json","markdown":"https://secwatch.observer/filing/0001493152-22-000042.md","text":"https://secwatch.observer/filing/0001493152-22-000042.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1453593/000149315222000042/0001493152-22-000042-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1453593/000149315222000042/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T21:20:12.004645+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0ef49151ce","claim":"Scott Neils was appointed as Interim Chief Financial Officer at Xtant Medical Holdings, Inc..","evidence_excerpt":"announced the appointment of Scott Neils as Interim Chief Financial Officer","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1453593/000149315222000042/0001493152-22-000042-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"ac04c04380","claim":"Greg Jensen was terminated as Vice President, Finance and Chief Financial Officer at Xtant Medical Holdings, Inc..","evidence_excerpt":"whose employment terminated effective as of January 3, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1453593/000149315222000042/0001493152-22-000042-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"terminated"},{"label":"Role","value":"Vice President, Finance and Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}